Innate Pharma S.A. (IPH.PA)
EUR 1.98
(-3.37%)
EUR 1.98
(-3.37%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -32.55 Million | -19.15 Million | -58.45 Million | -51.8 Million | 34.92 Million | -32.53 Million |
| Net Income | -7.57 Million | -58.1 Million | -52.8 Million | -63.98 Million | -20.75 Million | 3.04 Million |
| Depreciation & Amortization | 5.09 Million | 45.4 Million | 4.59 Million | 56.79 Million | 16.52 Million | 7.4 Million |
| Deferred income taxes | -32 Million | - | -1.68 Million | 2.65 Million | -4.14 Million | 1.15 Million |
| Stock-based compensation | 4.25 Million | 4.24 Million | 2.61 Million | 2.47 Million | 3.82 Million | 2.7 Million |
| Change in working capital | -32.09 Million | -12.5 Million | -9.88 Million | -49.2 Million | 40.24 Million | -47.09 Million |
| Other non-cash items | 29.75 Million | 1.79 Million | -1.29 Million | -544 Thousand | -774 Thousand | 253 Thousand |
| Investing Cash Flow | 20.63 Million | 1.87 Million | -917 Thousand | -13.37 Million | -62.12 Million | 24.27 Million |
| Investments in PPE | -2.35 Million | -1.12 Million | -1.33 Million | -11.28 Million | -65.4 Million | -1.42 Million |
| Acquisitions | 150 Thousand | - | 7000.00 | 9000.00 | - | 22 Thousand |
| Investment purchases | 1000.00 | - | - | -3 Million | - | - |
| Sales/Maturities of investments | 22.76 Million | 3 Million | - | -9000.00 | 2 Million | 25.66 Million |
| Other Investing Activities | 66 Thousand | -1000.00 | 406 Thousand | 912 Thousand | 1.28 Million | 46 Thousand |
| Financing Cash Flow | -1.96 Million | -1.82 Million | 26.81 Million | -1.13 Million | 77.76 Million | 61.22 Million |
| Debt repayment | -2.36 Million | -2.02 Million | -2.06 Million | -2.2 Million | -1.98 Million | -1.34 Million |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | 395 Thousand | 198 Thousand | 499 Thousand | 49 Thousand | 66 Million | 62.55 Million |
| Other Financing Activities | 395 Thousand | -1.82 Million | 28.38 Million | 1.01 Million | 13.74 Million | 8000.00 |
| Accounts receivables | -13.66 Million | -4.2 Million | 3.39 Million | -22.91 Million | 110.29 Million | -130.69 Million |
| Accounts payables | -3.89 Million | -7.66 Million | -946 Thousand | -6.52 Million | 1.38 Million | 34.33 Million |
| Inventory | - | - | -6.27 Million | 25.38 Million | - | - |
| Other working capital | -14.53 Million | -636 Thousand | -6.06 Million | -45.13 Million | 38.86 Million | -47.09 Million |
| Cash at beginning of period | 84.22 Million | 103.75 Million | 136.79 Million | 202.88 Million | 152.31 Million | 99.36 Million |
| Cash at end of period | 70.6 Million | 84.22 Million | 103.75 Million | 136.79 Million | 202.88 Million | 152.31 Million |
| Capital Expenditure | -2.35 Million | -1.12 Million | -1.33 Million | -11.28 Million | -65.4 Million | -1.42 Million |
| Effect of forex changes on cash | 274 Thousand | -428 Thousand | -483 Thousand | 219 Thousand | 5000.00 | -26 Thousand |
| Net cash flow / Change in cash | -13.62 Million | -19.53 Million | -33.03 Million | -66.09 Million | 50.57 Million | 52.94 Million |
| Free Cash Flow | -34.91 Million | -20.27 Million | -59.78 Million | -63.08 Million | -30.47 Million | -33.96 Million |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -12.38 Million | -12.38 Million | -4.64 Million | -7.57 Million | -4.64 Million | 1.71 Million |
| Depreciation & Amortization | 571 Thousand | 571 Thousand | 723 Thousand | 5.09 Million | 723 Thousand | 3.64 Million |
| Deferred income taxes | - | - | -13.96 Million | -32 Million | - | -15.91 Million |
| Stock-based compensation | 853 Thousand | 853 Thousand | 1.42 Million | 4.25 Million | 1.42 Million | 700.5 Thousand |
| Change in working capital | 15.65 Million | 15.65 Million | -6.52 Million | -32.09 Million | -6.52 Million | -18.53 Million |
| Other non-cash items | -3.17 Million | -3.17 Million | -1.52 Million | 29.75 Million | -1.52 Million | 16.91 Million |
| Investing Cash Flow | 466 Thousand | 466 Thousand | 10.43 Million | 20.63 Million | 10.43 Million | -246 Thousand |
| Investments in PPE | -141.5 Thousand | -141.5 Thousand | -21 Thousand | -2.35 Million | -21 Thousand | -312 Thousand |
| Acquisitions | - | - | 150 Thousand | 150 Thousand | - | - |
| Investment purchases | - | - | -1.00 | 1000.00 | - | - |
| Sales/Maturities of investments | 1.21 Million | - | 22.76 Million | 22.76 Million | - | - |
| Other Investing Activities | 607.5 Thousand | 607.5 Thousand | 10.45 Million | 66 Thousand | 10.45 Million | 66 Thousand |
| Financing Cash Flow | -2.16 Million | -2.16 Million | -360 Thousand | -1.96 Million | -360 Thousand | -1.24 Million |
| Debt repayment | -4.42 Million | - | -767 Thousand | -2.36 Million | - | -1.59 Million |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | 93 Thousand | - | 47 Thousand | 395 Thousand | - | 348 Thousand |
| Other Financing Activities | -2.16 Million | -2.16 Million | -360 Thousand | 395 Thousand | -360 Thousand | -623 Thousand |
| Accounts receivables | 15.91 Million | 15.91 Million | -4.83 Million | -13.66 Million | -4.83 Million | -4 Million |
| Accounts payables | -1.14 Million | - | 27 Thousand | -3.89 Million | - | -3.92 Million |
| Inventory | - | - | - | - | - | - |
| Other working capital | -264 Thousand | -264 Thousand | -1.69 Million | -14.53 Million | -1.69 Million | -10.6 Million |
| Cash at beginning of period | 70.6 Million | - | 71.41 Million | 84.22 Million | - | 84.22 Million |
| Cash at end of period | 69.99 Million | -308 Thousand | 70.6 Million | 70.6 Million | -403.5 Thousand | 71.41 Million |
| Capital Expenditure | -141.5 Thousand | -141.5 Thousand | -21 Thousand | -2.35 Million | -21 Thousand | -312 Thousand |
| Effect of forex changes on cash | -128.5 Thousand | -128.5 Thousand | 64.5 Thousand | 274 Thousand | 64.5 Thousand | 72.5 Thousand |
| Net cash flow / Change in cash | -615 Thousand | -308 Thousand | -809 Thousand | -13.62 Million | -403.5 Thousand | -12.81 Million |
| Free Cash Flow | 1.37 Million | 1.37 Million | -10.56 Million | -34.91 Million | -10.56 Million | -11.77 Million |
IIFL
6020
2641
2941
011090